Sanofi (NASDAQ:SNY) has stopped shipping its anti-cholesterol therapy Praluent, developed with Regeneron (NASDAQ:REGN), as ...

Praluent has won the battle for UnitedHealth Group’s business in ongoing PCSK9 sweepstakes, according to an announcement this morning from Sanofi and Regeneron. UnitedHealth’s formularies will ...

Sanofi, Regeneron's Praluent pulls off PCSK9 coup with 29% cut to death risks in most vulnerable patients By Eric Sagonowsky Mar 10, 2018 9:00am ACC18 drug safety PCSK9 American College of Cardiology ...

Bridgewater-based Sanofi and Regeneron Pharmaceuticals will make Praluent available at a new U.S. list price of $5,850 annually, a 60 percent reduction from the original price, beginning in early ...

Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French ...

Praluent-treated patients started the trial on 75 mg every 2 weeks, and switched to 150 mg every 2 weeks if their LDL-C levels remained above 50 mg/dL (n=2,615).

Praluent and a similar drug, Amgen's Repatha, work in a different way and lower cholesterol much more. Patients give themselves shots of the medicine once or twice a month.

Results showed that the overall risk of major cardiovascular events (MACE) was reduced by 15% in patients who received Praluent with maximally-tolerated statins compared with those who remained on ...

Sanofi is pulling its PCSK9 drug Praluent from the Chinese market. President Donald Trump said U.S. pharmaceutical tariffs ...

Praluent is supplied in 2 dosage strengths, 75mg/mL and 150mg/mL, in a single-dose prefilled pen. In children aged 8 to 11 years, Praluent should be given by a caregiver following proper training.

Sanofi (NASDAQ:SNY) announced on Tuesday that it has stopped supplying Praluent in China due to limited availability of the popular cholesterol medication.

On the primary endpoint, Praluent reduced the overall risk of MACE by 15% (HR=0.85, CI: 0.78-0.93, p=0.0003). The MACE composite endpoint includes patients who experienced a heart attack, ischemic ...